LAUREN GROFF: Open Payments
NPI 1538873682 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,631 in 66 payments from 20 companies in 2025. Trend: 2023 $1,631 · 2024 $1,790 · 2025 $1,631
Food & beverage: $1,531Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 14 | $234 |
| Janssen Biotech, Inc. | 5 | $185 |
| Novartis Pharmaceuticals Corporation | 8 | $170 |
| Gilead Sciences, Inc. | 7 | $138 |
| Adaptive Biotechnologies Corporation | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 4 | $117 |
| Eisai Inc. | 4 | $115 |
| Genmab U.S., Inc. | 3 | $84 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| Astellas Pharma US Inc | 2 | $55 |
Products named: Enhertu, Trodelvy, ERLEADA, clonoSEQ, Lenvima, KISQALI, Epkinly, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
